Vaxcyte (PCVX) Selling, General & Administrative (2019 - 2026)

Vaxcyte (PCVX) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -10.08 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 555.10 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.47 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 17.02 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.13 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 101.25 Mn
10 Vaxcyte 7.76 Bn 7.76 Bn - 33.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 33.07 Mn
Dec 31, 2025 32.22 Mn
Sep 30, 2025 32.45 Mn
Jun 30, 2025 32.04 Mn
Mar 31, 2025 32.66 Mn
Dec 31, 2024 28.56 Mn
Sep 30, 2024 22.99 Mn
Jun 30, 2024 21.47 Mn
Mar 31, 2024 19.89 Mn
Dec 31, 2023 17.53 Mn
Sep 30, 2023 15.61 Mn
Jun 30, 2023 14.46 Mn
Mar 31, 2023 13.11 Mn
Dec 31, 2022 11.95 Mn
Sep 30, 2022 10.90 Mn
Jun 30, 2022 9.42 Mn
Mar 31, 2022 7.54 Mn
Dec 31, 2021 6.77 Mn
Sep 30, 2021 6.52 Mn
Jun 30, 2021 6.08 Mn